藥物成份
共有 20983 個藥物成份
Amoxicillin/Clavulanate, Ampicillin, Beta-Lactamase, Chloramphenicol, Ciprofloxacin, Clindamycin, Erythromycin, Gentamicin, Gentamicin-Synergy, Levofloxacin, Linezolid, Moxifloxacin, Nitrofurantoin, Oxacillin, Penicillin, Quinupristin/Dalfopristin, Rifampin, Streptomycin-Syergy, Teicoplanin, Tetracycline, Trimethoprim/Sulfamethoxazole, Vancomycin
Ampicillin (0.25, 1, 4, 16)、Ampicillin/Sulbactam (8/4, 16/8, 64/32)、Cefazolin (8, 16)、Ciprofloxacin (0.5, 1, 2)、Clindamycin (0.5, 4)、Erythromycin (0.5, 4)、Gentamicin (0.5, 2, 8)、Gentamicin-500 (500)、Nitrofurantoin (64)、Oxacillin (0.5, 2, 5)、Penicillin G (0.03, 0.25, 1, 4, 16)、Rifampin (0.25, 0.5, 1.5)、Streptomycin-2000 (2000)、Tetracycline (1, 8)、Trimeth/Sulfa (0.5/9.5(10), 4/76(80), 16/304(320))、Vancomycin (0.5, 4, 6, 16)、β-lactamase (Pen G/Ox) (1.15/0.03)(μg/mL).
Ampicillin, Ampicillin/Sulbactam, Cefazolin, Ciprofloxacin, Clindamycin, Erythromycin, Gentamicin, Gentamicin-500, Levofloxacin, Nitrodurantoin, Oxacillin, Penicillin G, Rifampin, Streptomycin-2000, Tetracyclin, Trimeth/Sulfa, Vancomycin, β-lactamase
Amplification Control (AC) Amplification Microwells, 4x96:\nRestriction enzyme ≧15 Units; DNA Polymerase ≧2 Units; dNTP’s ≧80 nmol;\nBDProbeTec ET (CT/GC) Control Set, 20 CT/GC Positive Controls (50 μL dried) containg 750 copies per reaction of pCT16 linearized plasmid* and 250 copies per reaction of pGC10 linearized plasmid* with ≧5 μg Salmon tests DNA;\n20 CT/GC Negative Controls (50 μL dried) with ≧5 μg Salmon tests DNA; BDProbeTec ET CT/GC Diluent Tubes-400 tubes each containing 2 mL of Sample Diluent, which contains potassium phosphate, DMSO, glycerol, Polysorbate 20, and 0.3% Proclin; BDProbeTec ET Diluent (CT/GC)-225 mL Sample Diluent which contains potassium phosphate, DMSO, glycerol, Polysorbate 20,and 0.03% Proclin.\n
Amplification and Detection Reagents: HBV MMX (COBAS TaqMan HBV Master Mix) 2 x 24 Tests, 2 x 1.4 mL: Tricine buffer, Potassium hydroxide, Potassium acetate, Glycerol, <0.001% dATP, dCTP, dGTP, dUTP, <0.001% Upstream and downstream primers to the Pre-Core/Core region of HBV, <0.001% Fluorescent-labeled oligonucleotide probes specific for HBV and the HBV Quantitation Standard, <0.001% Oligonucleotide aptamer, <0.05% Z05 DNA Polymerase (microbial), <0.1% AmpErase (uracil-N-glycosylase) enzyme (microbial), 0.09% Sodium azide; CTM Mn2+ (COBAS TaqMan Manganese Solution) 2 24 Tests, 2 x 1.0 mL: <1.2% Manganese acetate, Glacial acetic acid, 0.09% Sodium azide.
Anti-AFP-Coated Microtitration Strips：\nOne stripholder containing 96 microtitration wells coated with anti-AFP antibody.\nAFP Standard A / Sample Diluent：\nOne bottle, 5.0 mL, labeled A, containing 0 ng/mL AFP in a protein-based (BSA) buffer with a non-mercury preservative.\nAFP Standard B-F：\nFive vials, 0.6 mL each, labeled B-F, containing concentrations of approximately 5, 20, 100, 200 and 500 ng/mL AFP in a protein-based (BSA) buffer with a non-mercury preservative.\nAFP Controls：\nTwo vials, 0.6 mL each, Levels I and II, containing low and high concentrations of AFP in a protein-based (BSA) buffer with a non-mercury preservative.\nAssay Buffer ： (GREEN)\nOne bottle, 2.8 mL, containing a protein-based buffer with a non-mercury preservative.\nAFP Antibody-Enzyme Conjugate Concentrate：\nOne vial, 0.5 mL, containing anti-AFP antibody conjugated to the enzyme horseradish peroxidase in a protein-based (BSA) buffer with a non-mercury preservative. Dilute prior to use in Assay Buffer A.\nTMB Chromogen Solution